Literature DB >> 22045270

Neuropsychological assessment of patients with dementing illness.

Julie A Fields1, Tanis J Ferman, Bradley F Boeve, Glenn E Smith.   

Abstract

Neuropsychological assessment has a distinct role in the detection and monitoring of cognitive and functional changes associated with dementing illness. Molecular, structural and functional neuroimaging studies have advanced our understanding of the anatomy and physiology underlying neurodegenerative disease; however, the overlap in pathological features of different dementia-associated diseases limits the information that can be obtained by these methods. Incorporation of information obtained from multiple sources can help to increase diagnostic and prognostic accuracy. Neuropsychological test findings provide unique value as biomarkers of dementia, as differentiators of disease topography and in the estimation of disease risk and trajectory. However, psychometric test properties--such as construct validity, stability and the use of appropriate norms--must be understood, because they influence both the application of neuropsychological tests and the interpretation of their results. Finally, measurement of cognitive strengths and weaknesses in patients at risk of dementia can be helpful to predict changes in functional abilities, design appropriate and effective interventions, and assist family and health-care providers in the planning of the patient's future care needs. This Review describes the key characteristics of neuropsychological testing in the assessment of patients at risk of dementia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045270     DOI: 10.1038/nrneurol.2011.173

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  99 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Mayo's older African American normative studies: confirmatory factor analysis of a core battery.

Authors:  Otto Pedraza; John A Lucas; Glenn E Smith; Floyd B Willis; Neill R Graff-Radford; Tanis J Ferman; Ronald C Petersen; Dawn Bowers; Robert J Ivnik
Journal:  J Int Neuropsychol Soc       Date:  2005-03       Impact factor: 2.892

3.  Memory enhancement training for older adults with mild cognitive impairment: a preliminary study.

Authors:  S Rapp; G Brenes; A P Marsh
Journal:  Aging Ment Health       Date:  2002-02       Impact factor: 3.658

4.  Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses.

Authors:  Robert M Chapman; Mark Mapstone; Anton P Porsteinsson; Margaret N Gardner; John W McCrary; Elizabeth DeGrush; Lindsey A Reilly; Tiffany C Sandoval; Maria D Guillily
Journal:  J Clin Exp Neuropsychol       Date:  2010-10       Impact factor: 2.475

5.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

6.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

7.  Testing normal older people three or four times at 1- to 2-year intervals: defining normal variance.

Authors:  R J Ivnik; G E Smith; J A Lucas; R C Petersen; B F Boeve; E Kokmen; E G Tangalos
Journal:  Neuropsychology       Date:  1999-01       Impact factor: 3.295

8.  Clock drawing errors in dementia: neuropsychological and neuroanatomical considerations.

Authors:  Stephanie Cosentino; Angela Jefferson; Douglas L Chute; Edith Kaplan; David J Libon
Journal:  Cogn Behav Neurol       Date:  2004-06       Impact factor: 1.600

9.  Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia.

Authors:  J Vincent Filoteo; David P Salmon; Dawn M Schiehser; Amy E Kane; Joanne M Hamilton; Laurie M Rilling; John A Lucas; Vanessa Zizak; Douglas R Galasko
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

10.  A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?

Authors:  G E Smith; V S Pankratz; S Negash; M M Machulda; R C Petersen; B F Boeve; D S Knopman; J A Lucas; T J Ferman; N Graff-Radford; R J Ivnik
Journal:  Neurology       Date:  2007-07-10       Impact factor: 9.910

View more
  15 in total

1.  Functional brain networks and cognitive deficits in Parkinson's disease.

Authors:  Hugo-Cesar Baggio; Roser Sala-Llonch; Bàrbara Segura; Maria-José Marti; Francesc Valldeoriola; Yaroslau Compta; Eduardo Tolosa; Carme Junqué
Journal:  Hum Brain Mapp       Date:  2014-03-17       Impact factor: 5.038

2.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

3.  Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72.

Authors:  Rodolfo Savica; Anahita Adeli; Prashanthi Vemuri; David S Knopman; Mariely Dejesus-Hernandez; Rosa Rademakers; Julie A Fields; Jennifer Whitwell; Clifford R Jack; Val Lowe; Ronald C Petersen; Bradley F Boeve
Journal:  Arch Neurol       Date:  2012-09

Review 4.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

5.  Mild cognitive impairment and mild dementia: a clinical perspective.

Authors:  David S Knopman; Ronald C Petersen
Journal:  Mayo Clin Proc       Date:  2014-10       Impact factor: 7.616

6.  Universal health outcome measures for older persons with multiple chronic conditions.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-11-29       Impact factor: 5.562

7.  The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.

Authors:  Anahita Adeli; Rodolfo Savica; Val J Lowe; Prashanthi Vemuri; David S Knopman; Mariely Dejesus-Hernandez; Rosa Rademakers; Julie A Fields; Brian A Crum; Clifford R Jack; Ronald C Petersen; Bradley F Boeve
Journal:  Neurocase       Date:  2012-11-30       Impact factor: 0.881

8.  Distributed functional connectivity predicts neuropsychological test performance among older adults.

Authors:  Seyul Kwak; Hairin Kim; Hoyoung Kim; Yoosik Youm; Jeanyung Chey
Journal:  Hum Brain Mapp       Date:  2021-05-07       Impact factor: 5.038

9.  Mapping memory binding onto the connectome's temporal dynamics: toward a combined biomarker for Alzheimer's disease.

Authors:  Agustin Ibanez; Mario A Parra
Journal:  Front Hum Neurosci       Date:  2014-04-22       Impact factor: 3.169

10.  P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia.

Authors:  Mario A Parra; Lindsay Lorena Ascencio; Hugo Fenando Urquina; Facundo Manes; Agustín M Ibáñez
Journal:  Front Neurol       Date:  2012-12-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.